CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $419,000 | +4.5% | 1,351,000 | +34.7% | 0.00% | 0.0% |
| Q4 2019 | $401,000 | +55.4% | 1,003,211 | +22.4% | 0.00% | +100.0% |
| Q3 2019 | $258,000 | +113.2% | 819,348 | +75.3% | 0.00% | 0.0% |
| Q2 2019 | $121,000 | -54.3% | 467,425 | +90.7% | 0.00% | 0.0% |
| Q1 2019 | $265,000 | 0.0% | 245,078 | +60.1% | 0.00% | 0.0% |
| Q4 2018 | $265,000 | -74.7% | 153,122 | -15.2% | 0.00% | -75.0% |
| Q3 2018 | $1,048,000 | +0.4% | 180,574 | -25.9% | 0.00% | -20.0% |
| Q2 2018 | $1,044,000 | -69.4% | 243,759 | -58.0% | 0.01% | -66.7% |
| Q1 2018 | $3,411,000 | -9.5% | 580,972 | -28.8% | 0.02% | -6.2% |
| Q4 2017 | $3,767,000 | -37.1% | 815,628 | -25.2% | 0.02% | -38.5% |
| Q3 2017 | $5,988,000 | -5.3% | 1,090,397 | -0.7% | 0.03% | -10.3% |
| Q2 2017 | $6,324,000 | +640.5% | 1,097,945 | +641.1% | 0.03% | +625.0% |
| Q1 2017 | $854,000 | +7016.7% | 148,160 | +3597.5% | 0.00% | – |
| Q4 2015 | $12,000 | – | 4,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kalos Management, Inc. | 47,500 | $12,000 | 0.01% |
| Virtu Financial LLC | 94,842 | $25,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 467,425 | $121,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $6,000 | 0.00% |
| A.R.T. Advisors, LLC | 60,430 | $16,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 25,350 | $7,000 | 0.00% |
| MORGAN STANLEY | 1,019 | $0 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $6,000 | 0.00% |
| WOLVERINE TRADING, LLC | 30,900 | $8,000 | 0.00% |
| WOLVERINE TRADING, LLC | 26,779 | $7,000 | 0.00% |